Send us Feedback

Sinovac Biotech (SVA)
Analysis
SUMMARY
BULLS
BEARS
Data
STOCK CHART
QUOTE AND NEWS
Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
PR Newswire  May 8  Comment 
BEIJING, May 8, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of vaccines in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2012 before market on
Sinovac Files Annual Report on Form 20-F
PR Newswire  Apr 12  Comment 
BEIJING, April 12, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it has filed its 2011 Annual Report on Form 20-F with the U.S. Securities and Exchange
Sinovac Participates in Goldman Sachs/Gao Hua Healthcare Corporate Day in Hong Kong
PR Newswire  Apr 12  Comment 
BEIJING, April 12, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that management will attend the April 2012 Goldman Sachs/Gao Hua Healthcare Corporate Day in
Sinovac Reports Unaudited Fourth Quarter and Preliminary Full Year 2011 Financial Results
PR Newswire  Mar 29  Comment 
BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and preliminary full year financial results for the period ended
Sinovac Biotech (SVA) Independent Director Chup Hung Mok Resigns, New Appointee Named
StreetInsider.com  Mar 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Sinovac+Biotech+%28SVA%29+Independent+Director+Chup+Hung+Mok+Resigns%2C+New+Appointee+Named/7304919.html for the full story.
Sinovac Announces Director Appointment
PR Newswire  Mar 29  Comment 
Sinovac (SVA) Reports Publication of Positive EV71 Vaccine Data
StreetInsider.com  Mar 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sinovac+%28SVA%29+Reports+Publication+of+Positive+EV71+Vaccine+Data/7304900.html for the full story.
Sinovac's EV71 Vaccine Phase I Clinical Data for the Prevention of Epidemic Hand, Foot, Mouth Disease Published in Vaccine
PR Newswire  Mar 29  Comment 
Sinovac to Host Conference Call to Report Fourth Quarter 2011 Unaudited Financial Results
PR Newswire  Mar 21  Comment 
BEIJING, March 21, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of vaccines in China, today announced that it will release its unaudited financial results for the fourth quarter ended December 31, 2011 before
Sinovac (SVA) Begins Phase III for EV71 Against HFMD
StreetInsider.com  Jan 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sinovac+%28SVA%29+Begins+Phase+III+for+EV71+Against+HFMD/7070759.html for the full story.
Sinovac (SVA) Director Chup Hung Mok Resigns
StreetInsider.com  Jan 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Sinovac+%28SVA%29+Director+Chup+Hung+Mok+Resigns/7052906.html for the full story.
Sinovac Biotech (SVA) Unit Receives Production License for Rabies Vaccine
StreetInsider.com  Sep 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sinovac+Biotech+%28SVA%29+Unit+Receives+Production+License+for+Rabies+Vaccine/6812979.html for the full story.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Sinovac_Biotech_(SVA)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki